Aldose reductase inhibition by .gamma.-oxo-8-fluoranthenebutanoi

Details Aldose reductase inhibition by .gamma.-oxo-8-fluoranthenebutanoi Aldose reductase inhibition by .gamma.-oxo-8-fluoranthenebutanoi

1981-08-17

1982-11-30

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

A61K 3119

Patent

active

043615821

ABSTRACT:
Disclosed are new methods of using .gamma.-oxo-8-fluoranthenebutanoic acid, or a therapeutically acceptable salt thereof with an organic or inorganic base for the treatment of complications associated with diabetes mellitus. The compound inhibits lens aldose reductase in a diabetic mammal.

REFERENCES:
patent: 2560425 (1951-07-01), Fancher
patent: 3821383 (1974-06-01), Sestanj et al.
Gastroenterology, 37 735 (1959).

Affiliated with

Also associated with

Rating

Aldose reductase inhibition by .gamma.-oxo-8-fluoranthenebutanoi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aldose reductase inhibition by .gamma.-oxo-8-fluoranthenebutanoi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibition by .gamma.-oxo-8-fluoranthenebutanoi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-195709